Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.
Press releases published on October 2, 2025
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
BOTHELL, Wash., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the Noble Capital Markets Emerging Growth Virtual Equity …
Nuvini Group Announces Reverse Stock Split
NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading serial acquirer in the Latin American SaaS sector, today announced that its Board of Directors has approved a 10-to-1 reverse stock split …
ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer
PRINCETON, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a comprehensive …
SONORO GOLD ANNOUNCES FULLY SUBSCRIBED $3 MILLION PRIVATE PLACEMENT
“THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.” VANCOUVER, Canada, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: …
Draig Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study of DT-101 for the Treatment of Major Depressive Disorder
DT-101 is designed to allow effective modulation of the AMPA receptor without compromising safety Phase 2 clinical trial initiation anticipated before the end of 2025 Trial builds on positive Phase 1 study that showed DT-101 was well tolerated and …
Incentive Program for the Conversion of BDRs into Shares
ROAD TOWN, British Virgin Islands, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (NASDAQ: AUGO; B3: AURA33) (“Aura” ou “Companhia”) Announces to the holders of the Company’s Brazilian Depositary Receipts ("BDRs") the launch of the Incentive Program …
Erdene Announces Updated Resource for the Zuun Mod Molybdenum-Copper Deposit
HIGHLIGHTS 100% owned license hosts one of Asia’s largest undeveloped molybdenum-copper deposits Only 35 kilometers from Erdene Mongol’s Bayan Khundii Gold Mine in region of growing infrastructure and 180 kilometres from China, the world’s largest …
AM-Pharma Completes Enrollment in Phase 2 Study of Ilofotase Alfa for Prevention of Cardiac Surgery-Associated Renal Damage
Utrecht, The Netherlands, October 2, 2025 – AM-Pharma B.V. today announced that it has successfully completed enrollment of patients in its ongoing Phase 2 clinical trial evaluating ilofotase alfa for the prevention of cardiac surgery-associated renal …
Fortuna expands West African presence, forms exploration alliance in Guinea with DeSoto Resources
VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to announce it has executed a binding Heads of Agreement (HOA) with DeSoto Resources Limited, an Australian-listed gold exploration …
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be …